方法275例初治鼻咽癌进入本研究。
Methods 275 patients with newly diagnosed NPC were enrolled.
目的探讨初治空洞型肺结核介入治疗的有效性和安全性。
Objective To assess the significance of interventional therapy on cavitary pulmonary initial treatment tuberculosis of lungs.
与初治耐药率比较，复治耐药率对4种药物有不同程度升高。
The acquired drug tolerance rate to the four kinds of drug increased in different quantities compared to the initial drug tolerance rate.
结果初治涂阳肺结核患者血清抗结核抗体总阳性率为46.3%；
Results It showed that the total positive rate of anti-tuberculosis antibody was 46.3%.
方法采用流式细胞仪对53例初治急性白血病进行免疫表型分析。
Methods Immune phenotypes were assayed in 53 patients with acute Leukemia by flow cytometer.
方法采用间接免疫荧光法分析102例初治all患者的免疫表型。
Method Immunophenotypes were examined using indirect immunofluorescence method in 102 denovo ALL.
目的分析228例初治培阳肺结核病人其耐药性与短化疗效的关系。
Objective To analyze the relationship between the drug resistance and the short course chemotherapy effect in 228 new smear positive pulmonary tuberculosis patients.
方法：采用体外照射加腔内后装放疗，初治中晚期宫颈癌患者114例。
Methods: 114 patients with middle and advanced stage cervical carcinoma received external beam radiotherapy to pelvis plus brachytherapy.
初治化疗的原则为低危患者以单药化疗为主，高危患者采用多药联合化疗。
The primary chemotherapy principle was that one agent was used for those patients with low-risk factors and two or multiple-agents were used for those patients with high-risk factors.
结论鼻咽癌初治患者的细胞免疫抑制与临床病期有关，还与HBV感染相关。
Conclusion the cellular immunity suppression in untreated patients with nasopharyngeal carcinoma is related with the clinical tumor stage, and can be influenced by HBV infection.
恩替卡韦治疗慢性乙型肝炎：大多数的部分病毒学应答初治患者无需剂量调整。
Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naive patients with a partial virological response...
方法：选取25例初治或复治MM病人，采用沙利度胺联合VAD、VTD等方案治疗。
Methods:25 newly diagnosed or relapsed MM cases were treated with T-VAD or T-VTD.
目的分析934例初治鼻咽癌单纯常规外照射放疗的临床效果，探讨提高疗效的临床因素。
Objective To analyze the clinical outcome of 934 primary nasopharyngeal carcinoma treated with conventional external beam radiotherapy alone.
标准治疗导致出现持续病毒学反应（SVR）的复治和初治患者比例分别为38%和81%。
Standard of care resulted in sustained virological response (SVR) rates of 38% and 81% in treatment-experienced and treatment-naïve patients, respectively.
目的检测P170糖蛋白在初治老年急性髓系白血病（AML）的表达，并探讨其与预后的关系。
Objective To explore the expression of P170 protein in untreated elder AML and its correlation with prognosis.
结论采用循证医学的方法为初治的老年弥漫性大B细胞淋巴瘤患者制定化疗方案可有效提高治疗效果。
Conclusions the treatment effectiveness in newly diagnosed diffuse large-B-cell lymphoma in the elderly has been improved by an individual treatment plan according to evidence-based methods.
目的评价深圳市宝安区1993 ~ 1999年常住、暂住初治涂阳肺结核病人直接督导化疗的转归。
Objective To evaluate the DOTS effect of new smear positive cases with pulmonary tuberculosis in Baoan District, Shenzhen, 1993 ~ 1999.
目的观察利妥昔单抗联合CHOP方案(R - CHOP)治疗初治弥漫大B细胞型淋巴瘤的疗效以及毒副反应。
Objective to observe the effect and toxicity of rituximab and CHOP regimen (R-CHOP) in the treatment of initially diagnosed diffuse large B-cell lymphoma.
目的探讨腹膜后淋巴结切除术在初治及复发卵巢恶性生殖细胞肿瘤（OGCT）患者中对肿瘤复发及患者生存的影响。
Objective To evaluate the impact of lymphadenectomy on the relapse and survival of malignant ovarian germ cell tumor(OGCT).
结论：MMC、VDS、DDP联合化疗治疗晚期非小细胞肺癌，有效率较高，毒性可以耐受，尤其适用于初治患者。
Conclusion: a higher response rate is attainable in patients with advanced NSCLC treated by MMC, VDS and DDP with tolerable toxicity, especially in patients who had not been treated with chemotherapy.
结论TATS对初治及复发APL有一定的诱导分化作用，单药TATS治疗初治及复发apl患者可达到血液学和细胞遗传学缓解。
Conclusion TATS has a differentiation inducing effect on untreated and recurrent APL, with haematological CR and cytogenetic CR achieved.
目的观察四硫化四砷（TATS）治疗初治和复发急性早幼粒细胞白血病（APL）过程中细胞形态学及细胞遗传学变化，探讨其作用机制。
Objective To study the morphologic and cytogenetic change in acute promyelocytic leukemia (APL) patients during the tetra arsenic tetra sulfide (TATS) treatment and the mechanism of TATS.
同时配对比较初治骨关节结核患者治疗前与治疗1月后外周血T淋巴细胞亚群的变化。结果：共有52例初治骨关节结核、18例恶性骨肿瘤及52例健康对照纳入本研究。
T lymphocyte subsets in Peripheral Blood of new cases with osteoarticular tuberculosis were compared with those from 18 patients with malignant primary or metastatic bone tumor and 52 normal controls.
结果初治药物敏感性患者平均DALY值为0.26人年，初治耐药患者为0.68人年；复治药物敏感性患者平均DALY值为0.49人年，复治耐药患者为1.04人年。
Results The average DALYs of initial cases with drug-sensitive and drug-resistant TB, and retreated cases with drug-sensitive and drug-resistant TB, were 0.26, 0.68, 0.49, and 1.04, respectively.
方法用碱性磷酸酶-抗碱性磷酸酶（APAAP）免疫酶标和DNA末端原位标记（ISEL）双重染色方法检测38例急性白血病诱导化疗前后骨髓涂片中细胞凋亡程度及细胞类型，初治组17例与2 1例经治病例对照。
Methods A double-stained way of APAAP and in situ DNA end labeling (ISEL) were used to detect apoptosis characteristics in 38 cases of acute leukemia, including 17 untreated and 21 treated patients.
方法用碱性磷酸酶-抗碱性磷酸酶（APAAP）免疫酶标和DNA末端原位标记（ISEL）双重染色方法检测38例急性白血病诱导化疗前后骨髓涂片中细胞凋亡程度及细胞类型，初治组17例与2 1例经治病例对照。
Methods A double-stained way of APAAP and in situ DNA end labeling (ISEL) were used to detect apoptosis characteristics in 38 cases of acute leukemia, including 17 untreated and 21 treated patients.
应用推荐